양성자 치료 가속기 시장 보고서 : 동향, 예측, 경쟁 분석(-2031년)
Proton Therapy Accelerator Market Report: Trends, Forecast and Competitive Analysis to 2031
상품코드 : 1815110
리서치사 : Lucintel
발행일 : 2025년 09월
페이지 정보 : 영문 150 Pages
 라이선스 & 가격 (부가세 별도)
US $ 3,850 ₩ 5,572,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. PDF 파일은 DRM(디지털 저작권 관리 시스템)이 장착되어 있습니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 4,650 ₩ 6,730,000
PDF (2 Users License) help
PDF 보고서를 동일 사업장에서 2명까지 이용할 수 있는 라이선스입니다. PDF 파일은 DRM(디지털 저작권 관리 시스템)이 장착되어 있습니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 5,350 ₩ 7,743,000
PDF (5 Users License) help
PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. PDF 파일은 DRM(디지털 저작권 관리 시스템)이 장착되어 있습니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 7,050 ₩ 10,204,000
PDF (Corporate License) help
PDF 보고서를 기업 내 모든 분이 이용할 수 있는 라이선스입니다. 이용 인원에 제한은 없으나, 국내에 있는 사업장만 해당되며, 해외 지점 등은 포함되지 않습니다. PDF 파일은 DRM(디지털 저작권 관리 시스템)이 장착되어 있습니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

세계 양성자 치료 가속기 시장의 미래는 방사선 치료 및 영상 진단 시장에 기회가 있을 것으로 보입니다. 세계 양성자 치료용 가속기 시장은 2025-2031년까지 12.1%의 연평균 성장률을 보일 것으로 예상됩니다. 이 시장의 주요 촉진요인은 암 발병률의 증가와 첨단 암 치료에 대한 수요, 양성자 치료 센터에 대한 투자 및 확장의 증가입니다.

양성자 치료용 가속기 시장의 새로운 동향

양성자 치료용 가속기 시장은 기술 발전, 전 세계 암 발병률 증가, 정밀의료 도입 확대로 인해 빠르게 성장하고 있습니다. 몇 가지 새로운 트렌드가 시장을 형성하고 있으며, 보다 효율적이고 비용 효율적인 치료 옵션의 개발로 이어지고 있습니다. 다음은 세계 양성자 치료용 가속기 시장의 5가지 주요 동향입니다.

소형화, 비용 절감, AI 통합, 소아암 치료에 대한 집중, 전 세계 양성자 치료 센터의 확장 등 새로운 세계 트렌드가 세계 양성자 치료 가속기 시장을 재편하고 있습니다. 이러한 추세는 양성자 치료의 보급을 촉진하고, 첨단 암 치료에 대한 접근성을 확대하며, 치료 결과를 향상시키고 있습니다. 기술이 계속 발전하고 비용이 낮아짐에 따라 양성자 치료는 더 많은 환자들에게 표준 치료 옵션으로 자리 잡게 될 것이며, 이는 시장에서 큰 성장 기회를 창출할 것입니다.

양성자 치료용 가속기 시장의 최근 동향

양성자 치료용 가속기 시장은 특히 기술 발전, 전 세계 암센터에서의 채택 확대, 신흥 시장 진출 등 몇 가지 중요한 발전을 확인했습니다. 주요 개발 내용은 다음과 같습니다.

세계 양성자 치료 가속기 시장의 이러한 발전은 현재 진행 중인 기술 발전, 암 치료에 대한 전 세계적인 수요 증가, 양성자 치료에 대한 접근성 확대에 따른 것으로 분석됩니다. 컴팩트한 시스템, AI 통합, R&D 투자 증가 등의 혁신으로 인해 양성자 치료용 가속기 시장은 전 세계적으로 지속적인 성장과 채택이 예상됩니다.

목차

제1장 주요 요약

제2장 시장 개요

제3장 시장 동향과 예측 분석

제4장 세계의 양성자 치료 가속기 시장(유형별)

제5장 세계의 양성자 치료 가속기 시장(용도별)

제6장 지역 분석

제7장 북미의 양성자 치료 가속기 시장

제8장 유럽의 양성자 치료 가속기 시장

제9장 아시아태평양의 양성자 치료 가속기 시장

제10장 기타 중동 및 아프리카의 양성자 치료 가속기 시장

제11장 경쟁 분석

제12장 기회와 전략 분석

제13장 밸류체인 전체에 걸친 주요 기업 개요

제14장 부록

KSM
영문 목차

영문목차

The future of the global proton therapy accelerator market looks promising with opportunities in the radiation therapy and diagnostic imaging markets. The global proton therapy accelerator market is expected to grow with a CAGR of 12.1% from 2025 to 2031. The major drivers for this market are the rising incidence of cancer and demand for advanced cancer treatments and the increasing investment and expanding proton therapy centers.

Emerging Trends in the Proton Therapy Accelerator Market

The proton therapy accelerator market is experiencing rapid growth due to evolving technological advancements, increasing global cancer rates, and the growing adoption of precision medicine. Several emerging trends are shaping the market, leading to the development of more efficient and cost-effective treatment options. The following are five key trends in the global proton therapy accelerator market:

Emerging trends like miniaturization, cost reduction, AI integration, the focus on pediatric cancer treatment, and the global expansion of proton therapy centers are reshaping the global proton therapy accelerator market. These trends are driving greater adoption of proton therapy, expanding access to advanced cancer treatments, and improving treatment outcomes. As technology continues to evolve and costs decrease, proton therapy is poised to become a standard treatment option for a broader patient population, creating significant growth opportunities in the market.

Recent Developments in the Proton Therapy Accelerator Market

The Proton Therapy Accelerator market has witnessed several important developments, particularly in terms of technological advancements, increased adoption in global cancer centers, and expansion into emerging markets. Key developments include:

These developments in the global proton therapy accelerator market highlight the ongoing advancements in technology, increasing global demand for cancer treatment, and the expanding access to proton therapy. With further innovations in compact systems, AI integration, and increased R&D investment, the proton therapy accelerator market is poised for continued growth and adoption worldwide.

Strategic Growth Opportunities in the Proton Therapy Accelerator Market

The global proton therapy accelerator market is poised for significant growth due to increasing cancer prevalence, advancements in technology, and a growing demand for precision cancer treatments. As proton therapy accelerators become more cost-effective and accessible, healthcare providers are finding new ways to incorporate them into a broader range of clinical applications. The key growth opportunities are spread across various therapeutic areas, from pediatric oncology to the treatment of complex tumors. These opportunities are reshaping the proton therapy market, encouraging investment and adoption worldwide.

The proton therapy accelerator market is witnessing tremendous growth due to the expanding use of proton therapy in pediatric oncology, brain and spinal tumor treatments, head and neck cancers, reirradiation procedures, and the growing demand in emerging markets. Each of these applications presents unique opportunities for growth, driving investment and technological innovation in the proton therapy sector. As healthcare providers continue to recognize the value of proton therapy, particularly in complex and sensitive cases, the global proton therapy accelerator market is set to experience sustained expansion, improving cancer treatment outcomes across the globe.

Proton Therapy Accelerator Market Driver and Challenges

The growth of the proton therapy accelerator market is driven by a combination of technological advancements, increasing cancer rates, and the rising demand for precise, targeted treatment options. However, the market also faces several challenges related to cost, infrastructure, and regulatory barriers. Understanding these drivers and challenges is key to evaluating the future potential of the proton therapy accelerator market.

The factors responsible for driving the proton therapy accelerator market include:

1. Technological Advancements in Proton Therapy: Technological innovations are a key driver of the proton therapy accelerator market. Advances such as smaller, more compact systems and more efficient delivery mechanisms have reduced the cost and increased the accessibility of proton therapy. The development of pencil beam scanning technology allows for greater precision in tumor targeting, minimizing radiation exposure to healthy tissues. As these technologies continue to evolve, the cost of proton therapy equipment will decrease, making it more affordable and widespread, driving demand for proton therapy accelerators.

2. Increasing Cancer Prevalence: The growing incidence of cancer worldwide is a major driver of the proton therapy accelerator market. Proton therapy is particularly useful for treating complex and hard-to-reach tumors, such as those located near vital organs or in pediatric patients. As cancer rates continue to rise globally, the demand for advanced cancer treatment technologies like proton therapy is expected to increase. This will result in greater investments in proton therapy accelerators and an expanded market for these devices, particularly in regions with high cancer rates.

3. Precision Medicine and Personalized Treatment: The increasing shift toward precision medicine is driving demand for proton therapy accelerators. Proton therapy offers highly targeted treatment, allowing for precise tumor targeting while sparing surrounding healthy tissue, which is crucial for personalized care. The growing focus on personalized treatment protocols, which take into account the unique genetic makeup of tumors and patients, has boosted the need for proton therapy. Proton therapy's ability to deliver tailored treatment options for cancer patients has positioned it as a key player in the evolution of precision medicine.

4. Improved Access to Healthcare in Emerging Markets: The expansion of proton therapy centers into emerging markets represents a significant growth driver. As emerging economies improve their healthcare infrastructure and increase investment in cancer care, proton therapy accelerators are being adopted in these regions. With rising cancer incidence in countries like China, India, and those in Africa and Latin America, there is a growing need for advanced treatment options, including proton therapy. The global expansion of proton therapy centers in these markets is opening up new revenue streams and driving growth in the proton therapy accelerator market.

5. Supportive Government Policies and Funding: Government initiatives and funding are playing a crucial role in driving the growth of the proton therapy accelerator market. In many countries, governments have recognized the potential of proton therapy in providing better cancer treatment outcomes and are investing in its infrastructure. Public funding and policy support for cancer treatment innovation have led to the development of more proton therapy centers. These efforts to subsidize the cost of proton therapy infrastructure and make it more accessible have resulted in increased adoption of proton therapy accelerators.

Challenges in the proton therapy accelerator market are:

1. High Initial Cost and Infrastructure: Despite technological advancements, the high initial cost of proton therapy accelerators remains a significant challenge. The construction of proton therapy centers requires substantial investment in both equipment and infrastructure. Smaller hospitals or clinics in developing countries may find it difficult to justify the cost, especially in comparison to other, less expensive forms of radiation therapy. High installation and operational costs are limiting the widespread adoption of proton therapy, despite its clinical benefits.

2. Regulatory and Reimbursement Barriers: Regulatory hurdles and reimbursement challenges also pose significant barriers to the growth of the proton therapy accelerator market. In many countries, proton therapy is not yet widely reimbursed by public health insurance systems, which makes it less accessible to patients. In addition, obtaining approval for new proton therapy technologies can be a lengthy and complex process, delaying the introduction of innovative systems. Regulatory frameworks must evolve to address these challenges and streamline the approval process, which will be key to accelerating market growth.

3. Limited Availability of Trained Professionals: The need for skilled medical professionals trained in proton therapy is another challenge facing the market. As proton therapy becomes more widely adopted, there is an increasing demand for clinicians, physicists, and technicians with specialized knowledge in proton therapy treatment and operation. The shortage of trained professionals, particularly in emerging markets, can limit the effectiveness and expansion of proton therapy. Developing comprehensive training programs and increasing investment in human capital will be critical for the sustained growth of the market.

The proton therapy accelerator market is driven by technological advancements, increasing cancer prevalence, precision medicine, expanding access in emerging markets, and supportive government policies. However, the market faces challenges such as high initial costs, regulatory and reimbursement barriers, and the shortage of trained professionals. Addressing these challenges through technological innovation, streamlined regulatory processes, and increased investment in healthcare infrastructure and workforce training will be essential to fully realizing the growth potential of the proton therapy accelerator market.

List of Proton Therapy Accelerator Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies proton therapy accelerator companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the proton therapy accelerator companies profiled in this report include-

Proton Therapy Accelerator Market by Segment

The study includes a forecast for the global proton therapy accelerator market by type, application, and region.

Proton Therapy Accelerator Market by Type [Value from 2019 to 2031]:

Proton Therapy Accelerator Market by Application [Value from 2019 to 2031]:

Proton Therapy Accelerator Market by Region [Value from 2019 to 2031]:

Country Wise Outlook for the Proton Therapy Accelerator Market

The global proton therapy accelerator market has experienced significant advancements in recent years, driven by technological innovations, increasing cancer rates, and rising demand for advanced, targeted cancer treatments. Proton therapy is a highly precise radiation treatment that targets tumors while minimizing damage to surrounding healthy tissues. The development of compact and cost-effective proton therapy systems has expanded accessibility worldwide. In this context, this section reviews the latest developments in the proton therapy accelerator market for the United States, China, Germany, India, and Japan.

Features of the Global Proton Therapy Accelerator Market

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers following 11 key questions:

Table of Contents

1. Executive Summary

2. Market Overview

3. Market Trends & Forecast Analysis

4. Global Proton Therapy Accelerator Market by Type

5. Global Proton Therapy Accelerator Market by Application

6. Regional Analysis

7. North American Proton Therapy Accelerator Market

8. European Proton Therapy Accelerator Market

9. APAC Proton Therapy Accelerator Market

10. ROW Proton Therapy Accelerator Market

11. Competitor Analysis

12. Opportunities & Strategic Analysis

13. Company Profiles of the Leading Players Across the Value Chain

14. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기